James E. Frampton
Impact in
- Pharmaceutical Science top 2%
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
- Migraine and Headache Studies
Papers in
-
- Migraine and Headache Studies 5
-
- Treatment of Major Depression 5
- Co-authors
- Greg L. Plosker (6 shared papers)Gary Steven Frost (2 shared papers)Edward S. Chambers (2 shared papers)Lesley J. Scott (6 shared papers)Kevin G. Murphy (1 shared paper)Rachel H. Foster (4 shared papers)Clive H. Orchard (5 shared papers)Mark R. Boyett (3 shared papers)
- Journals
- Drugs (74 papers)CNS Drugs (12 papers)BioDrugs (11 papers)Drugs & Aging (9 papers)American Journal of Clinical Dermatology (7 papers)
- Partner nations
- New ZealandUnited StatesUnited Kingdom
In The Last Decade
James E. Frampton
149 papers receiving 5.0k citations
James E. Frampton's Hit Papers
Peers
Comparison fields: 5 of 106
- Pharmaceutical Science 122
- Psychiatry and Mental health 278
- Cardiology and Cardiovascular Medicine 340
- Pharmacology 162
- Nephrology 117
Countries citing papers authored by James E. Frampton
This map shows the geographic impact of James E. Frampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Frampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Frampton more than expected).
Fields of papers citing papers by James E. Frampton
This network shows the impact of papers produced by James E. Frampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Frampton. The network helps show where James E. Frampton may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Frampton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function Hit paper breakdown → | 2020 | 393 |
| 2 | 1994 | 147 | |
| 3 | 2005 | 132 | |
| 4 | 1991 | 124 | |
| 5 | 1992 | 117 | |
| 6 | 2018 | 116 | |
| 7 | 2004 | 95 | |
| 8 | 2010 | 95 | |
| 9 | 1992 | 94 | |
| 10 | 2020 | 90 | |
| 11 | 2007 | 88 | |
| 12 | 2014 | 84 | |
| 13 | 2020 | 83 | |
| 14 | 2007 | 81 | |
| 15 | 2022 | 79 | |
| 16 | 2003 | 78 | |
| 17 | 2016 | 78 | |
| 18 | 1995 | 77 | |
| 19 | 2018 | 74 | |
| 20 | 2013 | 67 |
About James E. Frampton
James E. Frampton is a scholar working on Psychiatry and Mental health, Pharmacology, Cardiology and Cardiovascular Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 149 papers that have together received 5.4k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (5 papers), Lung Cancer Treatments and Mutations (5 papers), Migraine and Headache Studies (5 papers), Treatment of Major Depression (5 papers), Cardiac electrophysiology and arrhythmias (5 papers), HIV/AIDS drug development and treatment (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). The work is most often cited by research in Pharmaceutical Science (122 citations), Psychiatry and Mental health (278 citations), Cardiology and Cardiovascular Medicine (340 citations), Pharmacology (162 citations) and Nephrology (117 citations). James E. Frampton has collaborated with scholars based in New Zealand, United States and United Kingdom. Frequent co-authors include Greg L. Plosker, Gary Steven Frost, Edward S. Chambers, Lesley J. Scott, Kevin G. Murphy, Rachel H. Foster, Clive H. Orchard, Mark R. Boyett, Diana M. Faulds and Monique P Curran. Their work appears in journals such as Drugs, CNS Drugs, BioDrugs, Drugs & Aging and American Journal of Clinical Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.